CBT-1

N/A

Report date: 2024/11/11 20:00:37
NME

Base Information

Drug NameCBT-1
Drug Alias NameCBT-1
ClassificationNatural product/ExtractSmall molecules > Heterocyclic drugs
Mechanisms of ActionP-glycoprotein 1 inhibitors
TargetsP-glycoprotein 1
Therapy Area/IndicationsCarcinoma, Non-Small-Cell LungSarcoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesCba Research Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCba Research Corp
Active IndicationsN/A
Inactive IndicationsCarcinoma, Non-Small-Cell LungSarcoma

Other Information

ATC CodeN/A
Related LinksN/A